Compare RCEL & JHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RCEL | JHS |
|---|---|---|
| Founded | N/A | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 146.2M | 127.2M |
| IPO Year | 2018 | 1994 |
| Metric | RCEL | JHS |
|---|---|---|
| Price | $8.12 | $10.93 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $7.88 | N/A |
| AVG Volume (30 Days) | ★ 571.9K | 8.3K |
| Earning Date | 05-14-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 27.20 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $71,610,000.00 | N/A |
| Revenue This Year | $17.17 | N/A |
| Revenue Next Year | $49.82 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 11.45 | N/A |
| 52 Week Low | $3.22 | $10.74 |
| 52 Week High | $8.35 | $12.09 |
| Indicator | RCEL | JHS |
|---|---|---|
| Relative Strength Index (RSI) | 79.06 | 48.88 |
| Support Level | $3.62 | $10.76 |
| Resistance Level | N/A | $11.13 |
| Average True Range (ATR) | 0.51 | 0.05 |
| MACD | 0.37 | 0.01 |
| Stochastic Oscillator | 93.18 | 56.67 |
Avita is largely a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently used in most of the 140 US burn centers. Despite having product approval in Australia, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region, although international sales, particularly in Japan, are growing. Avita is domiciled, and has its primary listing, in the US.
John Hancock Income Securities Trust is a United States-based closed-end diversified management investment company. Its main objective is to generate a high level of current income consistent with prudent investment risk. The fund invests its net assets (plus borrowings for investment purposes) in income securities, consisting of marketable corporate debt securities, governmental obligations, and cash and commercial paper. A majority of its net assets are invested in debt securities that are rated, at the time of acquisition, investment-grade or in unrated securities determined by the Fund's investment advisor or subadvisor to be of comparable credit quality.